SMITHKLINE BEECHAM (CORK) LIMITED
11Patents
7Active
11Granted
40Portfolio score
Filing activity: Jun 28, 2001 → Jun 25, 2007 · 7 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7157466B2 | Quinazoline ditosylate salt compounds | Chemistry; Metallurgy | 45 | Expired |
| US7141576B2 | Cancer treatment method | Electricity | 33 | Expired |
| US7626041B2 | Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment | Human Necessities | 5 | Active |
| US7759384B2 | Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment | Human Necessities | 5 | Active |
| US8821927B2 | Pharmaceutical composition | Chemistry; Metallurgy | 2 | Active |
| US7902378B2 | Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment | Human Necessities | 2 | Active |
| US7446108B2 | Tri-and tetraaza-acenaphthylen derivatives as CRF receptor antagonists | Human Necessities | 2 | Expired |
| US8088779B2 | Pyrazolo [1,5-alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists | Human Necessities | 1 | Active |
| US6806280B1 | Polymorph of 5-[4-[2-(n-methyl-n(2-pyridyl)amino)ethoxy]benzyl]-thiazolidine-2,4-dione, maleic acid salt | Human Necessities | 1 | Expired |
| US7879862B2 | Pyrazolo[1,5-alpha]pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists | Human Necessities | 1 | Active |
| US7737154B2 | CRF receptor antagonists and methods relating thereto | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.